Table 3.
Characteristics of the ESLD and HF Cohorts at Index Hospitalization, Patients Aged ≥65 Yearsa
| Variable | ESLD (n = 22,311) | HF (n = 85,397) |
|---|---|---|
| Age (yrs), mean (SD) | 77.4 (7.6) | 81.7 (8.0) |
| Gender, male | 9491 (42.5%) | 32,129 (37.6%) |
| Race | ||
| Black | 1956 (8.8%) | 8192 (9.6%) |
| White | 19,021 (85.3%) | 73,787 (86.4%) |
| Other/Unknown | 1334 (6.0%) | 3418 (4.0%) |
| Other medical history | ||
| Cancer | 7733 (34.7%) | 14,983 (17.5%) |
| Chronic kidney disease | 8568 (38.4%) | 37,107 (43.5%) |
| COPD | 10,784 (48.3%) | 53,712 (62.9%) |
| Coronary artery disease | 12,100 (54.2%) | 65,786 (77.0%) |
| Diabetes mellitus | 10,707 (48.0%) | 42,743 (50.1%) |
| HF | 11,743 (52.6%) | 85,397 (100.0%) |
| Hypertension | 19,574 (87.7%) | 81,081 (94.9%) |
ESLD = end-stage liver disease; HF = heart failure; COPD = chronic obstructive pulmonary disease.
a
P-value for all comparisons <0.001.